✦ LIBER ✦
Continuous subcutaneous delivery of exenatide via ITCA 650 leads to sustained glycemic control and weight loss for 48 weeks in metformin-treated subjects with type 2 diabetes
✍ Scribed by Henry, Robert R.; Rosenstock, Julio; Logan, Douglas; Alessi, Thomas; Luskey, Kenneth; Baron, Michelle A.
- Book ID
- 122128646
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 375 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1056-8727
No coin nor oath required. For personal study only.